THYROID ASSOCIATED OPHTHALMOPATHY
Clinical trials for THYROID ASSOCIATED OPHTHALMOPATHY explained in plain language.
Never miss a new study
Get alerted when new THYROID ASSOCIATED OPHTHALMOPATHY trials appear
Sign up with your email to follow new studies for THYROID ASSOCIATED OPHTHALMOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody shows promise for thyroid eye disease in early trial
Disease control CompletedThis study tested a new drug called LASN01 in 41 adults with moderate-to-severe thyroid eye disease (TED). The drug is an antibody that blocks a protein involved in inflammation. The goal was to see if it could reduce eye bulging and other symptoms safely. Participants received e…
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHY
Phase: PHASE2 • Sponsor: Lassen Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New drug shows promise for stubborn thyroid eye disease
Disease control CompletedThis study tested a new medicine called IBI311 for people with thyroid eye disease that did not get better with steroids. The medicine is an antibody that blocks a protein linked to eye bulging and inflammation. The study involved 53 adults and measured if the treatment could red…
Matched conditions: THYROID ASSOCIATED OPHTHALMOPATHY
Phase: PHASE3 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 20, 2026 11:55 UTC